DXCM Dexcom Earnings and EPS analysis

EPS in 2026 (TTM): $2.59

Last Report Period Date: Jun 30, 2026

Currently, DXCM's trailing twelve months (TTM) EPS stands at $2.59, according to the most recent financial reports. Dexcom's earnings per share in 2025 came in at $2.14, marking an increase from $1.46 in 2024. DXCM recorded an EPS of $0.65 for the quarterly period ending on Jun 30, 2026.

In 2025, Dexcom's EPS was $2.14, an increase of 46.6% from $1.46 in 2024. The quarterly EPS for the period ending Jun 30, 2026, was $0.65, marking a 41.3% increase compared to the same quarter last year. DXCM's TTM EPS is $2.59 as of June 2026. Dexcom's EPS for 2024 was $1.46, a 4.3% rise from 2023.

Over the past 12 months, Dexcom has recorded an earnings per share growth of 41.3% (YoY, quarterly). Looking at a longer timeframe, the company recorded an average EPS annual growth rate of 34.5% per year for the last 3 years. Over the last five years, the company had an average annual EPS growth of 7.9%.